ArticleScientia pharmaceutica2018
Synthesis and Cytotoxicity Evaluation of Novel Asymmetrical Mono-Carbonyl Analogs of Curcumin (AMACs) against Vero, HeLa, and MCF7 Cell Lines.
Article in Scientia pharmaceutica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Antimalarial potential of curcumin derivatives evaluated through experimental and computational approaches.Scientific reports · 2025Article
- Investigations of the Flavin-Dependent Monooxygenase PhzO Involved in Phenazine Biosynthesis.Microbial biotechnology · 2025Article
- Preparation of nanosilver/polymer composites and evaluation of their antimicrobial and antitumor effect.RSC advances · 2025Article
- Regulation of adipocyte differentiation and lipid metabolism by novel synthetic chromenes exploring anti-obesity and broader therapeutic potential.Scientific reports · 2025Article
- Antiproliferative Activity and Apoptotic Mechanisms of β-Sitosterol and Its Derivatives as Anti-Breast Cancer Agents: In Silico and In Vitro.Journal of experimental pharmacology · 2025Article
- Glucospanlastics: innovative antioxidant and anticancer ascorbyl-2-glucoside vesicles for striking topical performance of repurposed itraconazole.RSC advances · 2024Article
- Article
- Article
- Preliminary insight on diarylpentanoids as potential antimalarials: In silico, in vitroHeliyon · 2024Article
- Article
- Synthesis, Characterization, and Antiproliferative Properties of New Bio-Inspired Xanthylium Derivatives.Molecules (Basel, Switzerland) · 2023Article
- Sustainable Green Synthesis of Yttrium Oxide (YNanomaterials (Basel, Switzerland) · 2022Article
- Formulation and evaluation of a smart drug delivery system of 5-fluorouracil for pH-sensitive chemotherapy.Heliyon · 2022Article
- Biodegradable Nanoparticles Loaded with Levodopa and Curcumin for Treatment of Parkinson's Disease.Molecules (Basel, Switzerland) · 2022Article
- Efficacy of surface-functionalized MgRSC advances · 2022Article
- Hybrid Synthetic and Computational Study of an Optimized, Solvent-Free Approach to Curcuminoids.ACS omega · 2022Article
- Synthesis, Molecular Docking, and Antimalarial Activity of Hybrid 4-Aminoquinoline-pyrano[2,3-c]pyrazole Derivatives.Pharmaceuticals (Basel, Switzerland) · 2021Article
- Investigation on Optical and Biological Properties of 2-(4-Dimethylaminophenyl)benzothiazole Based Cycloplatinated Complexes.Chemistry (Weinheim an der Bergstrasse, Germany) · 2021Article
- In Vitro Antifungal Activity and Toxicity of Dihydrocarvone-Hybrid Derivatives againstAntibiotics (Basel, Switzerland) · 2021Article
- Accelerated Solvent Extractions (ASE) ofMolecules (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A series of novel asymmetrical mono-carbonyl analogs of curcumin (AMACs) were synthesized and evaluated for cytotoxic activity using BSLT and MTT assay against Vero, HeLa, and MCF7 cell lines. The structures of the synthesized compounds were confirmed by FTIR, ¹H-NMR,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.